# Angle Health hits $2.7B valuation with $200M Series C

> Y Combinator insurance tech startup raises major funding round without AI focus, proving non-AI startups can still command big valuations.
- Title: Angle Health hits $2.7B valuation with $200M Series C
- Summary: Y Combinator insurance tech startup raises major funding round without AI focus, proving non-AI startups can still command big valuations. Angle Health's…
- Keywords: angle health, y combinator, series c funding, health insurance, level-funded plans, small business, vitruvian partners, startup valuation, insurance tech, employee tender offer, technology, startups
- Source: TechCrunch — https://techcrunch.com/2026/09/18/y-combinator-insurance-tech-alum-angle-health-hits-2-7b-valuation
- Author: Julie Bort
- Published: 2026-09-18T20:24:33+00:00
- Read time: 1 min
- Topics: angle health, y combinator, series c funding, health insurance, level-funded plans, small business, vitruvian partners, startup valuation, insurance tech, employee tender offer, technology, startups
## Angle Health reaches $2.7B valuation
The Y Combinator insurance tech startup raised $200 million in Series C funding alongside a $400 million employee tender offer, led by Vitruvian Partners.
## What Angle Health actually does
The startup helps small businesses obtain and manage level-funded health plans, which sit between fully insured and self-funded options, offering predictable costs with potential savings.
## AI-powered platform for small business
Angle Health's platform uses AI to help small businesses choose and manage plans, integrating with payroll and HR systems to streamline the process.
## Serving 5,000 businesses profitably
Angle Health says it serves over 5,000 businesses and has already achieved profitability, a rare milestone for a startup founded in 2019.
## Non-AI startup still commands big money
Angle Health's $2.7B valuation proves that startups not focused on AI agents can still raise substantial Series C funding and achieve unicorn status.
## Key takeaway

Angle Health's $2.7B valuation shows that profitable, non-AI startups solving real business problems can still raise significant capital and achieve unicorn status.